Global Smoking Cessation Market Analysis & Forecasts - Preparing For The First Blockbuster

By Author: Bharat Book Bureau
Total Articles: 1477
Comment this article

Cigarette smoking is the most important source of preventable and premature morbidity worldwide. Currently, the number of smokers across the globe is estimated at 1.3 billion. Political moves are leading to national bans of smoking in public places, with the long-term aim to reduce the cost to the health sector. But what will be the short-term spending on smoking cessation therapies?

In 2007, we believe the anti-smoking market to be worth $1.7 billion. This is a growth of 37% from the year before. This latest report, Global Smoking Cessation Market Analysis & Forecasts - preparing for the first blockbuster, explains just how this market will experience growth over the medium term future. Also do you know what the drivers and restraints of the market are? This report not only reveals these, but also details what strategies can be used to maximize profits from the drivers and restraints.

The report examines key smoking cessation markets such as :
- US
- Japan
- Canada
- Germany
- France
- Italy
- Spain
- UK
- Sweden
- Australia
...
...
In this report each one of these disease areas is examined in terms of market growth and revenue. Plus we examine how current and new drug treatments will take hold in each market, plus which companies will succeed in each market.

According to the findings of this new report, it reveals that the nicotine vaccine market will generate over $1 billion plus that Pfizer's nicotinic receptor will be the markets first blockbuster drug.

Can any of these drugs compete with the OTC market leaders? How will GSK's Zyban be effected with direct competition from Chantix/ Champix? However are there any others which can compete with this for market share or beat its dominance? This report answers that question, with an analysis of other players in the market.

The report provides in-depth market analysis upon these areas, and extensively identifies both prescription and OTC smoking cessation drugs by product type. The study also assess' the challenges faced by anti-smoking companies, and what exciting market opportunities exist in this up- and-coming therapeutic area.

Why You Must Buy This Report?
This report features tables, graphs and charts, news, insights, the latest developments and an in depth survey of the anti-smoking market with up-to-date analysis. This report is a vital addition to gaining an understanding of this profitable market sector and will give your company 'the edge' on your competitors. You can not afford to be without this latest report.

With unmet medical needs this market and a growing user base, by how much will the market grow? Enough for some products to begin to lose revenue? This report will tell you. Brought together in one easy to read, easily digested format, this report will keep you fully informed and up-to-date on the global ophthalmic pharmaceutical market.

For more information, Please visit : http://www.bharatbook.com/detail.asp?id=52067

bharatbook.com, a leading information aggregator, facilitates and supports the business information needs for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more. With over 90,000 reports, you can get instant access and insights on the studies in your areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com